Class 536/29.11 - N-hetero ring bonded directly or indirectly to the acyclic nitrogen

Subclass of Class 536 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein a nitrogen containing hetero ring is bonded
No. of patents: 30
Last issue date: 11/11/2008

Number	Title	Issue Date
7449570	Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases The invention encompasses nucleoside compounds, compositions comprising the compounds and methods for treating or preventing diseases associated with nonsense mutations of mRNA by administering these compounds or compositions. ...	11/11/2008
7390790	Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use One embodiment of the invention relates to compounds of the formula I, in which R1, R2, R3, R4, R5 and R6 have the meanings given in the specification. Other embodiments of the invention relate to physiologically acceptable...	06/24/2008
7378518	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof The present invention provides compounds represented by the structural formula (I): or pharmaceutically acceptable isomers, salts, solvates or esters of the compound of Formula (I), wherein each of the substituents is as sp...	05/27/2008
7368562	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof The present invention provides compounds represented by the structural formula (I): or pharmaceutically acceptable isomers, salts, solvates or esters of the compound of Formula (I), wherein each of the substituents is as sp...	05/06/2008
7368563	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof The present invention provides compounds represented by the structural formula (I): or pharmaceutically acceptable isomers, salts, solvates or esters of the compound of Formula (I), wherein each of the substituents is as sp...	05/06/2008
7235543	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof The present invention provides compounds represented by the structural formula (I): or pharmaceutically acceptable isomers, salts, solvates or esters of the compound of Formula (I), wherein each of the substituen...	06/26/2007
7208486	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof The present invention provides compounds represented by the structural formula (I): or pharmaceutically acceptable isomers, salts, solvates or esters of the compound of Formula (I), wherein each of the substituen...	04/24/2007
7192944	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof The present invention provides compounds represented by the structural formula (I): or pharmaceutically acceptable isomers, salts, solvates or esters of the compound of Formula (I), wherein each of the substituen...	03/20/2007
7153956	Cyanine dye having multifunctional peripheral groups The present invention provides an IR-absorbing dye of formula (I) or (II) wherein R10, R13, R20, R23, R30, R33, R40 and R	12/26/2006
7144879	Substituted metal-phthalocyanines, their preparation and the use thereof The present invention is directed to metal-phthalocyanines of general formula (I) to the corresponding conjugates, the processes for their preparation and use in the photodynamic therapy of microbial infections (viral, bacterial and mycotic), tumor, pre-cancerous an...	12/05/2006
7005517	Paramagnetic metal-phthalocyanine complex compounds and contrast agent using the same The present invention provides a novel paramagnetic metal-phthalocyanine complexes and pharmaceutically acceptable salts thereof, which are useful as contrast agents for MRI(Magnetic Resonance Imaging), diagnostic X-ray imaging and computed tomography(CT). Th...	02/28/2006
7005518	Phthalocyanine dyes Fluorescent dyes are disclosed which are useful as reporter groups for labeling biomolecules. The silicon phthalocyanine dyes disclosed are preferably water soluble, isomericly pure, possess high quantum yield, and are useful in bioassays. ...	02/28/2006
6407064	Aminoalcohol derivative and medicament comprising the same An aminoalcohol derivative which is a ceramide analogue, and a medicament, especially an agent for treating neuronal diseases and an agent for protecting brain, comprising the same....	06/18/2002
6362170	Benzylglycosylamides as inhibitors of smooth muscle cell proliferation This invention provides smooth muscle cell proliferation inhibitors of formula I having the structure ##STR1## wherein Y is C or N; where n is 0-3; X is ##STR2## R1, and R2 are each independently, hydrogen, alkyl of 1 to 6 carbo...	03/26/2002
6339064	Benzylglycosylamides as inhibitors of smooth muscle cell proliferation This invention provides smooth muscle cell proliferation inhibitors of formula I having the structure ##STR1## wherein Y is C or N; where n is 0-3; X is ##STR2## R1, and R2 are independently, hydrogen, alkyl of 1 to 6 carbon ato...	01/15/2002
6329531	Optical diagnostic agents for diagnosis of neurodegenerative diseases by means of near infrared radiation (NIR radiation) The invention relates to compounds of formula (I): Fm (--A1)(--Bn)(--Wo) wherein F is a colorant-signal molecule with a maximum absorption value ranging from 600-1200 nm; A is a ଲ-amyloid plaque binding biomolecule; ...	12/11/2001
6277831	1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar residues, process for their preparation, pharmaceuticals comprising these compounds, and their use The invention relates to substituted 1,4-benzothiazepine-1,1-dioxide derivatives and their acid addition salts. 1,4-Benzothiazepine-1,1-dioxide derivatives of formula 1, ##STR1## wherein R1, R2, R3, and Z have the meanings indi...	08/21/2001
5633261	Immunostimulating swainsonine analogs Immunostimulting swainsonine derivatives and methods for their synthesis are provided....	05/27/1997
5591758	Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases Organic nitrates, processes for their preparation and their use in the treatment of vascular diseases and in particular in the treatment of angina. The said nitrates correspond to the following formula I: R--CO--(A)n --Y--B ...	01/07/1997
5556941	Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds N-Glycopeptide derivatives of the formula I ##STR1## where aromatic is an unsubstituted or substituted benzene residue, naphthalene re...	09/17/1996
5501957	Method for measuring glycosyltransferase activity A method of assaying for glycosyltransferase activity in a sample. In a first step, a sample is reacted with a first sugar donor and an acceptor substrate to produce a transferase product. The first sugar donor and acceptor substrate are selected such tha...	03/26/1996
5484778	Phthalocyanine photosensitizers for photodynamic therapy and methods for their use The present invention relates to a series of novel phthalocyanine compositions (or compounds) suitable for use as photosensitizers for photodynamic therapy. Specifically, the invention relates to a series of new aluminum (Al) germanium (Ge), gallium (Ga),...	01/16/1996
5367062	Disubstituted and deoxydisubstituted derivatives of ଱-d-lyxofuranosides having anti-inflammatory and anti-proliferative activity Derivatives of disubstituted and deoxydisubstituted ଱-D-lyxofuranosides and intermediates for preparing these derivatives are described. These compounds exhibit significant antiinflammatory and anti-proliferative activity and are useful for tre...	11/22/1994
5256394	Radiological imaging method, and contrast media reagents therefor A method of imaging a corporeal situs by radiological techniques, comprising delivery to the corporeal situs of an imagingly effectively amount of a physiologically acceptable composition comprising a boron reagent. A variety of illustrative boron reagent...	10/26/1993
5091523	Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof The invention relates to certain derivatives of mitomycins A and C and the use thereof to treat bacterial infections and to supress the growth of cancer cells. The invention also relates to processes for the preparation of the mitomycin derivatives of the...	02/25/1992
4999424	GAR transformylase inhibitor The present invention is directed to several multisubstrate adduct inhibitors of glycinamide ribonucleotide transformylase (GAR TFase; E.C. 2.1.2.2), a folate-requiring enzyme of de novo purine biosynthesis. The compounds of the present invention will be ...	03/12/1991
4845090	Nitroxyl compound and diagnostic media based thereon useful for enhancing NMR imaging Diagnostic media suitable for NMR diagnoses contain compounds of Formula I ##STR1## wherein is a single bond or a double bond, X is the grouping --(CH2)n -- or, if is a single bond, also the grouping --NHCO(CH2)	07/04/1989
4560748	Streptothricin-group compounds A streptothricin-group compound having the formula: ##STR1## in which R represents ##STR2## is disclosed along with methods for producing this compound and a microorganism useful in its production....	12/24/1985
4434175	Nonsteroidal compounds as anti-inflammatory and analgesic agents 5-Aroyl-4-RO-, 5-aroyl-4-RS-, 5-aroyl-4-RSO-, 5-aroyl-4-RSO2 -, or 5-pyrrylcarbonyl-pyrrole alkanoic acid have been prepared via hydrolysis of a precursor-ester after high temperature decarboxylation or from direct acidic decarboxylation of a p...	02/28/1984
4086416	Septacidin analogs Septacidin analogs, useful as antitumor agents, having the structure ##STR1## where R is a branched or straight chain alkanoyl group of from 12 to 16 carbon atoms. A preferred compound is 6-[4,6-dideoxy-4-(isopalmitoylglycyl)-amino-ଲ-L-glucopyr...	04/25/1978

PatentStorm

Bizarre Patents

PatentStorm News

Class 536/29.11 - N-hetero ring bonded directly or indirectly to the acyclic nitrogen